MetLife, Inc.
MET
$76.56
$0.230.30%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.80% | 1.86% | 2.08% | 1.75% | 5.13% |
| Total Other Revenue | -73.16% | 303.19% | 202.77% | 148.30% | 171.20% |
| Total Revenue | 0.82% | 6.17% | 8.76% | 6.09% | 12.38% |
| Cost of Revenue | 2.59% | 1.60% | 1.68% | 0.81% | 6.84% |
| Gross Profit | -4.33% | 22.01% | 35.99% | 26.29% | 32.38% |
| SG&A Expenses | -- | -- | -- | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 4.61% | 3.24% | 2.56% | -17.20% | -16.29% |
| Total Operating Expenses | 2.96% | 1.89% | 1.84% | 1.15% | 6.34% |
| Operating Income | -21.23% | 85.15% | 222.04% | 151.06% | 171.15% |
| Income Before Tax | -4.96% | 53.39% | 101.05% | 160.04% | 59.59% |
| Income Tax Expenses | -24.02% | 79.36% | 153.05% | 110.36% | 106.34% |
| Earnings from Continuing Operations | 2.09% | 46.44% | 88.92% | 177.40% | 47.26% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 0.00% | 50.00% | 44.44% | 25.00% | -5.00% |
| Net Income | 2.10% | 47.37% | 90.44% | 180.48% | 47.59% |
| EBIT | -21.23% | 85.15% | 222.04% | 151.06% | 171.15% |
| EBITDA | -19.25% | 70.57% | 165.69% | 113.85% | 134.79% |
| EPS Basic | 7.16% | 59.31% | 111.17% | 226.16% | 64.25% |
| Normalized Basic EPS | -0.10% | 63.17% | 115.77% | 180.89% | 74.07% |
| EPS Diluted | 7.35% | 59.54% | 110.93% | 225.89% | 63.99% |
| Normalized Diluted EPS | -0.13% | 63.13% | 115.72% | 180.76% | 74.16% |
| Average Basic Shares Outstanding | -5.60% | -6.10% | -6.51% | -6.77% | -6.67% |
| Average Diluted Shares Outstanding | -5.58% | -6.06% | -6.46% | -6.72% | -6.66% |
| Dividend Per Share | 4.46% | 4.63% | 4.81% | 4.61% | 4.41% |
| Payout Ratio | -0.04% | -0.33% | -0.48% | -0.65% | -0.33% |